Skip to main content

Ulcerative Colitis Videos

David Rubin
Video
10/15/2024
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
Dr Rubin discusses the results...
10/15/2024
Advances in Inflammatory Bowel Disease Network
Phillip Gu
Video
09/07/2024
Dr Gu recaps his talk from the Los Angeles regional meeting on the most critical factors in caring for patients with acute severe ulcerative colitis, including testing for C difficile, involving the surgeon early, and ensuring patients...
Dr Gu recaps his talk from the Los Angeles regional meeting on the most critical factors in caring for patients with acute severe ulcerative colitis, including testing for C difficile, involving the surgeon early, and ensuring patients...
Dr Gu recaps his talk from the...
09/07/2024
Advances in Inflammatory Bowel Disease Network
Gil Y. Melmed, MD
Video
09/07/2024
Dr Melmed reviews his presentation from the AIBD regional meeting in Los Angeles on using dat
Dr Melmed reviews his presentation from the AIBD regional meeting in Los Angeles on using dat
Dr Melmed reviews his...
09/07/2024
Advances in Inflammatory Bowel Disease Network
Ed Barnes
Video
07/17/2024
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on advances in the treatment of ulcerative colitis, including new therapies approved and how those therapies could change clinical practice.
Dr Barnes provides updates on...
07/17/2024
Advances in Inflammatory Bowel Disease Network
Laura Raffals
Video
06/13/2024
Dr Raffals reviews her top pearls for ensuring patients with ulcerative colitis are correctly diagnosed, properly treated and monitored, and benefit from multidisciplinary care.
Dr Raffals reviews her top pearls for ensuring patients with ulcerative colitis are correctly diagnosed, properly treated and monitored, and benefit from multidisciplinary care.
Dr Raffals reviews her top...
06/13/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference Coverage
06/06/2024
Dr Long discusses the management of acute severe ulcerative colitis, including initiating therapy, when and how to assess response, options for rescue treatment, and the role of the surgeon in determining the best course of care.
Dr Long discusses the management of acute severe ulcerative colitis, including initiating therapy, when and how to assess response, options for rescue treatment, and the role of the surgeon in determining the best course of care.
Dr Long discusses the management...
06/06/2024
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
04/30/2024
Dr Rubin provides an in-depth look at the treatment of ulcerative colitis, from setting patient expectations to positioning therapies and monitoring for disease remission or progression.
Dr Rubin provides an in-depth look at the treatment of ulcerative colitis, from setting patient expectations to positioning therapies and monitoring for disease remission or progression.
Dr Rubin provides an in-depth...
04/30/2024
Advances in Inflammatory Bowel Disease Network
Ray
Video
04/27/2024
Dr Cross reviews his presentation from the AIBD regional meeting on the use, safety, and positioning of Janus kinase inhibitors for the treatment of IBD.
Dr Cross reviews his presentation from the AIBD regional meeting on the use, safety, and positioning of Janus kinase inhibitors for the treatment of IBD.
Dr Cross reviews his...
04/27/2024
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
03/13/2024
Dr Rubin discusses the evolution of treatment goals with ulcerative colitis, including discussing with patients quality of life issues, urgency, functionality, and the potential for remission.
Dr Rubin discusses the evolution of treatment goals with ulcerative colitis, including discussing with patients quality of life issues, urgency, functionality, and the potential for remission.
Dr Rubin discusses the evolution...
03/13/2024
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Conference Coverage
11/08/2023
Dr Loftus, from Mayo Clinic in Rochester, Minnesota, reviews results from the phase 3 INSPIRE trial of risankizumab for induction of remission among patients with moderate to severe ulcerative colitis.
Dr Loftus, from Mayo Clinic in Rochester, Minnesota, reviews results from the phase 3 INSPIRE trial of risankizumab for induction of remission among patients with moderate to severe ulcerative colitis.
Dr Loftus, from Mayo Clinic in...
11/08/2023
Advances in Inflammatory Bowel Disease Network